| Market Cap | ₹26,647Cr |
| ROE | 19.21% |
| P/E Ratio(TTM) | 38.89 |
| EPS(TTM) | 43.75 |
| P/B Ratio | 7.76 |
| Dividend Yield | 0.91% |
| Industry P/E | 33.42 |
| Book Value | 219.25 |
| Debt to Equity | 0.01 |
| Face Value | 1 |
| Parent Organisation | JB Chemicals & Pharmaceuticals Limited |
| Managing Director | NA |
| NSE Symbol | JBCHEPHARM |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 82.27 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.53 | ||
| Wockhardt | NA (0.00%) | -426.40 | ||
| Concord Biotech | NA (0.00%) | 41.12 |